Topics

Chemoimmunotherapy Role in CLL Shifting With Rise of Novel Agents

12:07 EST 4 Dec 2019 | OncLive

Jonathon B. Cohen, MD, MS, discusses the integration of novel agents into clinical practice and the changing role of chemoimmunotherapy in chronic lymphocytic leukemia.

Original Article: Chemoimmunotherapy Role in CLL Shifting With Rise of Novel Agents

NEXT ARTICLE

More From BioPortfolio on "Chemoimmunotherapy Role in CLL Shifting With Rise of Novel Agents"

Quick Search

Relevant Topic

Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...